Info session on the Commission’s proposal for a Critical Medicines Act
In March 2025, the European Commission proposed the Critical Medicines Act (CMA) to improve the availability, supply and production of critical medicines within the EU. The CMA also aims to increase access to other medicines of common interest, such as those for rare diseases, and to address the fact that some medicines are not available in certain markets.
Read the news published by Directorate-General for Health and Food Safety on 30 April 2025.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (3 juin 2025). Info session on the Commission’s proposal for a Critical Medicines Act. ELSIBI. Consulté le 7 novembre 2026 à l’adresse https://doi.org/10.58079/141pm





